selected scholarly activity
-
chapters
- Arthritis: A Diagnostic Approach. 33-44. 2015
-
conferences
- Urine and Plasma Complement Ba Levels During Disease Flares in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis. Kidney International Reports. 2421-2427. 2023
- Ocular manifestations of ANCA-associated vasculitis. Rheumatology. 2517-2524. 2023
- Characteristics of Relapse of Individuals With ANCA-Associated Vasculitis Enrolled in the PEXIVAS Trial. Journal of Rheumatology. 20-20. 2023
- The Effects of Initial Treatment on Relapse of ANCA-Associated Vasculitis in the PEXIVAS Trial. Journal of Rheumatology. 21-21. 2023
- Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis. Arthritis Care and Research. 1806-1812. 2022
- Markers of Neutrophil Activation in Patients with ANCA-associated Vasculitis and Large-vessel Vasculitis. Arthritis & Rheumatology. 979-981. 2022
- Outcome Measures in Patients with Neurologic Involvement in ANCA-associated Vasculitis: Data from Multicenter Longitudinal Observational Study. Arthritis & Rheumatology. 870-872. 2022
- The Association Between Age of Diagnosis and Disease Characteristics and Damage in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis & Rheumatology. 1024-1027. 2022
- Ocular Manifestations of ANCA-associated Vasculitis. Journal of Rheumatology. 772-772. 2022
- Radiological Validation of a Novel MRI Reporting System for Axial Spondyloarthritis. Journal of Rheumatology. 785-785. 2022
- A Polyclonal Airway Autoimmune Response Is Associated with Clinical Indices of Asthma Severity. American Journal of Respiratory and Critical Care Medicine. 2022
- DURATION OF STEROID THERAPY AND TEMPORAL ARTERY BIOPSY POSITIVITY IN GIANT CELL ARTERITIS: A RETROSPECTIVE COHORT STUDY. Irish Journal of Medical Science. S33-S34. 2022
- Urine and Plasma Complement Ba Levels During Flares of Nephritis in Patients with ANCA-Associated Vasculitis. Journal of the American Society of Nephrology. 449-449. 2021
- Neurologic Involvement in ANCA-associated Vasculitis: Data from Multicenter Longitudinal Observational Study. Arthritis & Rheumatology. 856-858. 2021
- Neutrophil Extracellular Trap Formation in Patients with Vasculitis. Arthritis & Rheumatology. 3906-3907. 2021
- A Review of PAH Screening Practices of Patients in the Canadian Scleroderma Research Group Registry: Is It Time to Revise the Guidelines?. Journal of Rheumatology. 1183-1183. 2021
- Changes in Disease Features Do Not Differ Between SSc Patients Who Did versus Did Not Undergo Annual PAH Screening: Data from the Canadian Scleroderma Research Group Registry. Journal of Rheumatology. 1116-1117. 2021
- Radiological Validation of a Novel MRI Reporting System for Axial Spondyloarthritis. Journal of Rheumatology. 1116-1116. 2021
- Vasculitis in Patients With Rheumatoid Arthritis: A Descriptive Study. Journal of Rheumatology. 1176-1177. 2021
- Efficacy of leflunomide in the treatment of vasculitis. Clinical and Experimental Rheumatology. 114-118. 2021
- Azathioprine Compared to Mycophenolate Mofetil Treatment in Patients with Interstitial Lung Disease Associated with Systemic Sclerosis. American Journal of Respiratory and Critical Care Medicine. 2021
- Azathioprine Compared to Mycophenolate Mofetil Treatment in Patients with Interstitial Lung Disease Associated with Systemic Sclerosis. TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD. a1915-a1915. 2021
- Clinical Indices of Autoimmunity Do Not Predict Sputum Autoantibodies in Patients with Severe Eosinophilic Asthma: A Prospective Study. American Journal of Respiratory and Critical Care Medicine. 2021
- Care Gap in Patients with Systemic Sclerosis with CXR Findings Suggestive of Fibrosis. Arthritis & Rheumatology. 2020
- Prevalence of Thyroid Disease Among Patients with Vasculitis. Arthritis & Rheumatology. 2020
- Thyroid Disease in Patients with ANCA-Associated Vasculitis. Arthritis & Rheumatology. 2020
- Impact of diabetes, angiotensin‐converting enzyme inhibitor or angiotensin II receptor blocker use, and statin use on presentation and outcomes in patients with giant cell arteritis. APLAR Journal of Rheumatology. 1233-1239. 2020
- Biopsy-positive Versus Negative Giant Cell Arteritis: Clinical Presentation, Predictive Factors and Effect of Extra-long Biopsy Length. Journal of Rheumatology. 1123-1123. 2020
- Development of a Patient-Centred Iloprost and Alprostadil Infusion Information Sheet for Patients with Scleroderma. Journal of Rheumatology. 1086-1086. 2020
- Inter-Rater Reliability of the Bhavsar-Khalidi Clinical Scoring System for Risk Stratification of Giant Cell Arteritis. Journal of Rheumatology. 1059-1060. 2020
- Pituitary Disease in Granulomatosis with Polyangiitis: An International Collaborative Case Series. Journal of Rheumatology. 1089-1089. 2020
- Rationalizing Temporal Artery Magnetic Resonance Angiography in the Diagnosis of Giant Cell Arteritis. Journal of Rheumatology. 1076-1076. 2020
- Sacroiliitis and Spondyloarthritis in Patients with Giant Cell Arteritis - More than a Chance Occurrence. Journal of Rheumatology. 1050-1051. 2020
- The Effect of Pregnancy on the Progression of Scleroderma. Journal of Rheumatology. 1086-1087. 2020
- FRI0258 CUMULATIVE INCIDENCE, SURVIVAL AND PREDICTORS OF PULMONARY HYPERTENSION IN SYSTEMIC SCLEROSIS SUBSETS: PAH IS NOT INCREASED IN LIMITED VS DIFFUSE PATIENTS BY ADJUSTED COMPETING RISK ANALYSIS. Annals of the Rheumatic Diseases. 713-713. 2020
- Infliximab Therapy in Patients with Refractory Sarcoidosis: A Multicenter Retrospective Review. American Journal of Respiratory and Critical Care Medicine. 2020
- Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis. Rheumatology. 2203-2211. 2019
- Assessments of Quality of Life in Patients with Eosinophilic Granulomatosis with Polyangiitis. Arthritis & Rheumatology. 2019
- Clinical Manifestations of Patients with Eosinophilic Granulomatosis with Polyangiitis in a Large North American Cohort. Arthritis & Rheumatology. 2019
- Comparison of Arterial Patterns of Disease in Takayasu's Arteritis and Giant Cell Arteritis. Arthritis & Rheumatology. 2019
- Comparison of Patient Self-reported Data to Physician-driven Cohorts in Patients with Eosinophilic Granulomatosis with Polyangiitis. Arthritis & Rheumatology. 2019
- Rationalizing the Use of MRI of the Scalp Arteries in the Diagnosis of Giant Cell Arteritis Through Multivariable Predictive Modelling. Arthritis & Rheumatology. 2019
- The Cumulative Burden of Damage for Patients with Eosinophilic Granulomatosis with Polyangiitis. Arthritis & Rheumatology. 2019
- Scleroderma and Pregnancy: Worse Pulmonary Outcomes Following Pregnancy in Patients from the CSRG Registry. Journal of Rheumatology. 858-858. 2019
- Severe Ischemic Events in Takayasu Arteritis: A Canadian Retrospective Cohort. Journal of Rheumatology. 787-788. 2019
- YouTube as a Platform for Narrative Medicine: A Novel Approach to Promote Empathy and Awareness for Patients with Chronic Disease. Journal of Rheumatology. 766-767. 2019
- A CLINICAL SCORING SYSTEM FOR RISK STRATIFICATION OF GIANT CELL ARTERITIS. Rheumatology. 2019
- DIFFUSE ALVEOLAR HEMORRHAGE, PULMONARY NODULES AND INFILTRATES IN GRANULOMATOSIS POLYANGIITIS AND MICROSCOPIC POLYANGIITIS. A COHORT STUDY OF 736 PATIENTS. Rheumatology. 60-60. 2019
- FACTORS ASSOCIATED WITH DISEASE PROGRESSION IN PATIENTS WITH MYELOPEROXIDASE-ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-RELATED PULMONARY FIBROSIS. Rheumatology. 2019
- UTILIZATION OF CANADIAN HEALTHCARE ADMINISTRATIVE DATABASES TO ACCURATELY IDENTIFY CASES OF ANCA-ASSOCIATED VASCULITIS. Rheumatology. 2019
- Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis. Arthritis & Rheumatology. 2077-2086. 2018
- Candidate Biomarkers in ANCA-Associated Vasculitis Identified Using a Proteomic Approach. Arthritis & Rheumatology. 2018
- Discovery and Validation of Novel Disease Subsets in 806 Patients with Takayasu's Arteritis across Four International Cohorts. Arthritis & Rheumatology. 2018
- Plasma iC3b Level As a Biomarker of Disease Relapse in ANCA-Associated Vasculitis. Arthritis & Rheumatology. 2018
- Screening of Patients with Adult-Onset Idiopathic Polyarteritis Nodosa for Deficiency of Adenosine Deaminase 2. Arthritis & Rheumatology. 2018
- Biopsy-positive versus Negative Giant Cell Arteritis: Clinic Presentation and Predictive Factors. Journal of Rheumatology. 1061-1062. 2018
- Use of a Clinical Scoring System in Risk Stratifying Patients with Suspected Giant Cell Arteritis. Journal of Rheumatology. 1044-1045. 2018
- Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis. PLoS ONE. e0205768-e0205768. 2018
- Damage and Predictors of Damage in Takayasu's Arteritis. Arthritis & Rheumatology. 2017
- Discrepancies between Clinical- and Imaging-Based Assessments of Disease Activity in Takayasu's Arteritis. Arthritis & Rheumatology. 2017
- Longitudinal Angiographic Findings in Patients with Takayasu's Arteritis. Arthritis & Rheumatology. 2017
- Markers of Inflammation and Patient-Reported Measures As Predictors of Relapse in Giant Cell Arteritis. Arthritis & Rheumatology. 2017
- Pituitary Disease and Granulomatosis with Polyangiitis: A Collaborative Canadian Case Series and Review of the Literature. Arthritis & Rheumatology. 2017
- Pulmonary Manifestations in Microscopic Polyangiitis and Granulomatosis with Polyangiitis: A Multicenter Cohort Analysis. Arthritis & Rheumatology. 2017
- The Effect on Health-Related Quality of Life of Treatment for Remission Maintenance in ANCA-Associated Vasculitis Beyond 18 Months. Arthritis & Rheumatology. 2017
- Urinary Epidermal Growth Factor and Monocyte Chemoattractant Protein-1 As Biomarkers of Renal Involvement in ANCA-Associated Vasculitis. Arthritis & Rheumatology. 2017
- Sputum anti-neutrophil cytoplasmic antibodies in eosinophilic granulomatosis and polyangiitis patients with respiratory involvement. Allergy. European Journal of Allergy and Clinical Immunology. 756-756. 2017
- A Case Series of Two Presentations of Skull Base Inflammatory Pseudotumor Sparing the Orbit and a Review of the Literature Focusing on Steroids and Immunosuppressive Induction Regimens. Journal of Rheumatology. 886-886. 2017
- Pulmonary Arterial Hypertension and Pulmonary Fibrosis Screening in Systemic Sclerosis in Clinical Practice: Choosing Wisely or Missed Opportunities?. Journal of Rheumatology. 881-881. 2017
- A RANDOMIZED DOUBLE-BLIND TRIAL OF ABATACEPT AND GLUCOCORTICOIDS FOR THE TREATMENT OF TAKAYASU'S ARTERITIS. Rheumatology. 49-49. 2017
- ARTERIAL LESIONS IN GIANT CELL ARTERITIS. Rheumatology. 58-59. 2017
- DISCREPANCIES BETWEEN CLINICAL- AND IMAGING-BASED ASSESSMENTS OF DISEASE ACTIVITY IN TAKAYASU'S ARTERITIS. Rheumatology. 45-45. 2017
- IDENTIFICATION OF FUNCTIONAL AND EXPRESSION POLYMORPHISMS ASSOCIATED WITH RISK FOR ANTI-NEUTROPHIL CYTOPLASMIC AUTOANTIBODY-ASSOCIATED VASCULITIS. Rheumatology. 23-24. 2017
- LATE-ONSET RELAPSE IN PATIENTS WITH SYSTEMIC VASCULITIS. Rheumatology. 107-108. 2017
- PATIENT REPORTED OUTCOMES AS PREDICTORS OF FLARES IN TAKAYASU ARTERITIS. Rheumatology. 51-51. 2017
- PREVALENCE OF IMMUNOFLUORESCENT DEPOSITS IN ANCA ASSOCIATED VASCULITIS. Rheumatology. 38-38. 2017
- SPUTUM ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN EOSINOPHILIC GRANULAMATOSIS AND POLYANGIITIS (EGPA). Rheumatology. 17-17. 2017
- URINARY EPIDERMAL GROWTH FACTOR AS A BIOMARKER OF RENAL INVOLVEMENT IN ANCA-ASSOCIATED VASCULITIS. Rheumatology. 2017
- UTILITY OF MEASUREMENTS OF URINARY SOLUBLE CD163 & MCP1 IN THE IDENTIFICATION OF SUBTLE RENAL FLARES IN ANCA VASCULITIS. Rheumatology. 39-39. 2017
- Identification And Validation Of Unique And Shared M2 Macrophage Biomarkers Between Murine Models And Human Disease Using Bioinformatic Gene Expression Analysis. American Journal of Respiratory and Critical Care Medicine. 2017
- The Hsp90 Inhibitor Radicicol As A Bioinformatically-Derived Drug For M2 Macrophage Phenotype Inhibition. American Journal of Respiratory and Critical Care Medicine. 2017
- A Randomized Double-Blind Trial of Abatacept and Glucocorticoids for the Treatment of Takayasu's Arteritis. Arthritis & Rheumatology. 2016
- Arterial Lesions in Giant Cell Arteritis. Arthritis & Rheumatology. 2016
- Fatigue and Physical Functioning in Patients with Giant Cell Arteritis. Arthritis & Rheumatology. 2016
- Health-Related Quality of Life in Giant Cell Arteritis. Arthritis & Rheumatology. 2016
- Late-Onset Relapse in Patients with Systemic Vasculitis. Arthritis & Rheumatology. 2016
- New Insights into the Pathogenesis of Giant Cell Arteritis through a Genome-Wide Association Study. Arthritis & Rheumatology. 2016
- The Utility of Patient-Reported Outcomes in Predicting Disease Activity in Patients with Takayasu's Arteritis. Arthritis & Rheumatology. 2016
- Utility of Measurements of Urinary Soluble CD163 & MCP-1 in the Identification of Subtle Renal Flares in ANCA-Associated Vasculitis. Arthritis & Rheumatology. 2016
- Fecal Incontinence and Association with Bowel Dysfunction in Systemic Sclerosis: A Canadian Multicenter Study. Journal of Rheumatology. 1151-1151. 2016
- Giant Cell Arteritis Presenting with Bilateral Vertebral Artery Stenosis - A Case Report and Review of the Literature. Journal of Rheumatology. 1214-1215. 2016
- Leukotriene Receptor Antagonist Therapy Associated Eosinophilic Granulomatosis with Polyangiitis: A Case and Literature Review. Journal of Rheumatology. 1244-1244. 2016
- Recurrence of Scleroderma Renal Crisis in Transplanted Kidney Leading to Graft Failure. Journal of Rheumatology. 1198-1198. 2016
- A Randomized Double-Blind Trial of Abatacept and Glucocorticoids for the Treatment of Giant Cell Arteritis. Arthritis & Rheumatology. 2015
- Administration of Patient Reported Outcome Measurement Information System (PROMIS) Instruments By Computer Adaptive Testing in Patients with Systemic Vasculitis. Arthritis & Rheumatology. 2015
- Anticytokine Autoantibody Profiling in Five Types of Systemic Vasculitis. Arthritis & Rheumatology. 2015
- Damage Assessment in Giant Cell Arteritis. Arthritis & Rheumatology. 2015
- Damage Assessment in Takayasu's Arteritis. Arthritis & Rheumatology. 2015
- Fecal Incontinence and Association with Bowel Dysfunction in Systemic Sclerosis: A Canadian Multicenter Study. Arthritis & Rheumatology. 2015
- Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis Interstitial Lung Disease. Arthritis & Rheumatology. 2015
- Using Exome Sequencing to Identify Novel Genetic Associations with Granulomatosis with Polyangiitis Susceptibility. Arthritis & Rheumatology. 2015
- Safety and tolerability of pirfenidone (PFD) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)–The LOTUSS study. European Respiratory Journal. 2015
- Inflammatory Pseudotumour of the Skull Base: A Case Report and Review of the Literature. Journal of Rheumatology. 1329-1329. 2015
- Prevalence, Severity and Impact of Fecal Incontinence in Systemic Sclerosis: Preliminary Results of a Cross-Sectional Study. Journal of Rheumatology. 1326-1327. 2015
- T Cell Epitopes Stimulating TGF beta in Patients with Systemic Sclerosis: Towards a Vaccine. Journal of Rheumatology. 1315-1316. 2015
- Training the Rheumatologists of Tomorrow: The Learners Experience. Journal of Rheumatology. 1284-1285. 2015
- Training the Rheumatologists of Tomorrow: The WOMAC Experience. Journal of Rheumatology. 1310-1311. 2015
- Vasculitis in Patients with Inflammatory Bowel Diseases: A Study of 32 Patients and Systematic Review of the Literature. Journal of Rheumatology. 1279-1279. 2015
- SAT0433 Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease – the Lotuss Study. Annals of the Rheumatic Diseases. 816.2-816. 2015
- Safety And Tolerability Of Pirfenidone In Patients With Systemic Sclerosis-Associated Interstitial Lung Disease - The Lotuss Study. American Journal of Respiratory and Critical Care Medicine. 2015
- Accuracy of High Resolution MRI of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Study.. Arthritis & Rheumatology. S390-S391. 2014
- An Immunochip Study Confirms a Strong Contribution of HLA Class I and II Genes in the Susceptibility to Giant Cell Arteritis.. Arthritis & Rheumatology. S388-S389. 2014
- Biomarkers of Disease Activity in Vasculitis.. Arthritis & Rheumatology. S354-S354. 2014
- Genetic Susceptibility Loci of Idiopathic Interstitial Pneumonitis Do Not Represent Risk for Systemic Sclerosis.. Arthritis & Rheumatology. S327-S327. 2014
- The Relationship of ARMS2 Genotype with Idiopathic Inflammatory Vasculitis.. Arthritis & Rheumatology. S1245-S1246. 2014
- The Role of Macrophage Migration Inhibitory Factor (MIF) and MIF Gene Polymorphisms in the Pathogenesis of Granulomatosis with Polyangiitis.. Arthritis & Rheumatology. S819-S819. 2014
- Training the Rheumatologists of Tomorrow: The Canadian Experience.. Arthritis & Rheumatology. S1260-S1260. 2014
- Vasculitis and Inflammatory Bowel Diseases: A Study of 32 Patients with Both Conditions and Systematic Review of the Literature.. Arthritis & Rheumatology. S352-S352. 2014
- Venothromboembolism in Large Vessel Vasculitis.. Arthritis & Rheumatology. S351-S351. 2014
- Rheumatologists of Tomorrow: One School's Story. Journal of Rheumatology. 1512-1513. 2014
- Staphylococcus Aureus Infection following Facet Joint Injection Masquerading as Acute Polyarthritis and Polymyalgia Rheumatica. Journal of Rheumatology. 1483-1484. 2014
- SAT0576 Creating New Rheumatologists: the Canadian Experience. Annals of the Rheumatic Diseases. 798.3-799. 2014
- Cardiac Involvement In Granulomatosis With Polyangiitis. Arthritis and Rheumatism. S312-S312. 2013
- Clinical Value Of Commonly-Measured Laboratory Tests In Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss). Arthritis and Rheumatism. S319-S319. 2013
- Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss Syndrome): Comparison Of The Independent French Vasculitis Study Group and Italian-Pisa Patient Cohorts and Cross-Validation Of Cluster Analysis. Arthritis and Rheumatism. S321-S321. 2013
- Serum S100A8/S100A9 and S100A12 As a Marker Of Disease Activity In Giant Cell Arteritis. Arthritis and Rheumatism. S706-S706. 2013
- The Birmingham Vasculitis Activity Score As a Measure Of Disease Activity In Patients With Giant Cell Arteritis. Arthritis and Rheumatism. S707-S707. 2013
- Clinical value of commonly measured laboratory tests in eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Presse Medicale. 697-698. 2013
- Granulomatosis with polyangiitis (Wegener's) is associated with HLA-DPB1*04 and EMA6A gene variants. Evidence from a genome-wide analysis. Presse Medicale. 668-668. 2013
- Serum biomarkers during relapsing disease in eosinophilic granulomatosis with polyangiitis. Presse Medicale. 700-701. 2013
- New Disease Manifestations After Diagnosis in Six Types of Vasculitis.. Arthritis and Rheumatism. S1007-S1007. 2012
- Urinary Biomarkers in Vasculitis Associated with Anti-Neutrophil Cytoplasmic Antibodies.. Arthritis and Rheumatism. S1010-S1010. 2012
- Clinical and Serological Correlates of Systemic Sclerosis Sine Scleroderma: Findings from a Canadian Cohort. Journal of Rheumatology. 1724-1724. 2012
- Are Patients with ANCA-Associated Vasculitis Entered In Clinical Trials Representative of Patients Followed In Observational Cohorts?. Arthritis and Rheumatism. S923-S923. 2011
- Distribution of Large Artery Lesions in Takayasu's Arteritis Compared to Giant Cell Arteritis. Arthritis and Rheumatism. S587-S588. 2011
- Relapses Among Patients with Giant Cell Arteritis.. Arthritis and Rheumatism. S591-S592. 2011
- Amyloidosis and GCA/PMR: Case Report of a Rare Association. Journal of Rheumatology. 1176-1176. 2011
- Giant Cell Arteritis and MRI Evaluation of the Cranial Arteries. Journal of Rheumatology. 1138-1138. 2011
- Panniculitis/Fasciitis due to a Drug-Induced Neutrophilic Dermatosis: A case report. Journal of Rheumatology. 1182-1182. 2011
- Are patients with anti-ANCA-AAV entered into clinical trials representative of patients followed in observational cohorts?. Clinical and Experimental Immunology. 81-82. 2011
- Association between vascular physical examination findings and arteriographic lesions in subjects with LVV. Clinical and Experimental Immunology. 116-116. 2011
- Distribution of thoracic large arterial lesions in TA compared to GCA. Clinical and Experimental Immunology. 115-115. 2011
- IgA and IgG ANCAs modulate disease severity in a genetically dependent fashion. Clinical and Experimental Immunology. 77-78. 2011
- Measurement of health-related quality of life among patients with ANCA-AAV using the SF-36. Clinical and Experimental Immunology. 83-83. 2011
- Back to the Bedside - A Case of Systemic Lupus Erythematosus Associated with pANCA, cANCA and Anti-Scl Antibodies - Distilling the Diagnostic Dilemma and Literature Review. Journal of Rheumatology. 1316-1316. 2010
- Giant Cell Arteritis and MRI Evaluation of the Cranial Arteries. Journal of Rheumatology. 1283-1284. 2010
- Temporal Artery Biopsy... Does Length Really Matter?. Journal of Rheumatology. 1325-1326. 2010
- Use of Oral Contraceptive Pills in Patients with SLE - A Survey of Rheumtologists in Canada. Journal of Rheumatology. 1325-1325. 2010
- Ultrasound of the Hands and Feet: Effect on Rheumatologists' Diagnostic Confidence and Patient Management. Journal of Rheumatology. 2600-2600. 2009
- Angiopoietin-2 as a biomarker in ANCA-associated vasculitis. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 112-113. 2009
- Imaging of Large and Medium-Sized Vessel Vasculitis. American Journal of Roentgenology. 2009
- Ultrasound of the Hands and Feet: Effect on Rheumatologists' Diagnostic Confidence and Patient Management. American Journal of Roentgenology. 2009
- Decreasing Hospital Stay in Wegener's Granulomatosis - Analysis of a Tertiary Center Inpatient Experience.. Arthritis and Rheumatism. 4023-4024. 2008
- Assessment of reproductive history in systemic sclerosis. Arthritis and Rheumatism. S827-S827. 2008
- Malnutirition is common in systemic sclerosis: Results from the Canadian scleroderma research group database. Arthritis and Rheumatism. S381-S381. 2008
- Adherence to guidelines for the detection of pulmonary hypertension in patients with scleroderma. Journal of Rheumatology. 1180-1180. 2008
- CNS Wegener's granulomatosis presenting with Bell's palsy. Journal of Rheumatology. 1203-1203. 2008
- Factors associated with physician service use in systemic sclerosis. Journal of Rheumatology. 1172-1173. 2008
- MRI evaluation of scalp artery inflammation in patients with giant cell arteritis. Journal of Rheumatology. 1216-1217. 2008
- Oral contraceptives and systemic lupus erythematosus, current practice in Hamilton. Journal of Rheumatology. 1192-1192. 2008
- Resident evaluations: The use of evaluation cards in rheumatology ambulatory care. Journal of Rheumatology. 1201-1201. 2008
- Wegener's granulomatosis - Analysis of the Hamilton inpatient experience. Journal of Rheumatology. 1208-1208. 2008
- An algorithm for cardiopulmonary testing in systemic sclerosis. Annals of the Rheumatic Diseases. 200-200. 2007
- Corticosteroids in chikungunya viral polyarthritis in two Canadian travelers. Journal of Rheumatology. 1633-1633. 2007
- Knowledge dissemination strategies translate into improved post-fracture osteoporosis care. Journal of Bone and Mineral Research. S264-S264. 2005
-
journal articles
- Minimal Detectable Changes of the Health Assessment Questionnaire-Disability Index, Patient-Reported Outcomes Measurement Information System-29 Profile Version 2.0 Domains, and Patient Health Questionnaire-8 in People With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Cross-Sectional Study.. Arthritis Care and Research. 76:1549-1557. 2024
- A study of implementation factors for a novel approach to clinical trials: constructs for consideration in the coordination of direct-to-patient online-based medical research.. BMC Medical Research Methodology. 24:244. 2024
- Signal Regulatory Protein α Expression in Systemic Vasculitis. ACR Open Rheumatology. 6:634-640. 2024
- The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study.. The Lancet Rheumatology. 6:e684-e692. 2024
- Vessel wall MRI in giant cell arteritis: standardized protocol and scoring approach developed by an international working group.. Rheumatology. keae498. 2024
- Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids. Arthritis & Rheumatology. 76:1431-1438. 2024
- Plasma proteome profiling in giant cell arteritis. Annals of the Rheumatic Diseases. ard-2024-225868. 2024
- Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study. Arthritis & Rheumatology. 76:1120-1129. 2024
- Assessment of damage in Takayasu’s arteritis. Rheumatology. keae333. 2024
- Axial Spondyloarthritis: Does Magnetic Resonance Imaging Classification Improve Report Interpretation. Journal of Clinical Rheumatology. 30:145-150. 2024
- Experiences of telehealth during and after the COVID-19 pandemic and preferences for future care of people with systemic sclerosis: a cross-sectional study. The Lancet Rheumatology. 6:e660-e663. 2024
- Moderators of Loneliness Trajectories in People with Systemic Sclerosis During the COVID-19 Pandemic: A SPIN COVID-19 Cohort Longitudinal Study. International Journal of Behavioral Medicine. 31:352-362. 2024
- Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study. The Lancet Rheumatology. 6:e374-e383. 2024
- Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study. The Lancet Rheumatology. 6:e374-e383. 2024
- Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study. Journal of Neurology. 271:3309-3320. 2024
- Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS). American Journal of Respiratory and Critical Care Medicine. 209:1141-1151. 2024
- Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registry. Journal of American Academy of Dermatology. 90:605-607. 2024
-
The Association Between Age at Diagnosis and Disease Characteristics and Damage in Patients With
ANCA‐Associated Vasculitis. Arthritis & Rheumatology. 75:2216-2227. 2023 - Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative.. Clinical and Experimental Rheumatology. 41:2249-2256. 2023
-
Validity, Reliability, and Differential Item Functioning of English and French Versions of the
10‐Item Connor‐Davidson Resilience Scale in Systemic Sclerosis: A SclerodermaPatient‐Centered Intervention Network Cohort Study. Arthritis Care and Research. 75:2369-2378. 2023 -
Evaluation of Measurement Properties and Differential Item Functioning in the English and French Versions of the University of California, Los Angeles, Loneliness Scale‐6: A Scleroderma
Patient‐Centered Intervention Network (SPIN ) Study. Arthritis Care and Research. 75:2158-2165. 2023 - Mitochondrial-mediated inflammation and platelet activation in giant cell arteritis. Clinical Immunology. 255:109746-109746. 2023
- Autoinflammatory gene mutations associated with eosinophilia and asthma. Allergy, Asthma and Clinical Immunology. 19:76. 2023
- CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum. Rheumatology. 62:2646-2651. 2023
- Patterns of patient-reported symptoms and association with sociodemographic and systemic sclerosis disease characteristics: a scleroderma Patient-centered Intervention Network (SPIN) Cohort cross-sectional study. EClinicalMedicine. 62:102104-102104. 2023
- Duration of Steroid Therapy and Temporal Artery Biopsy Positivity in Giant Cell Arteritis: A Retrospective Cohort Study. Journal of Rheumatology. 50:965-966. 2023
- Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial. Annals of the Rheumatic Diseases. 82:937-944. 2023
- Added diagnostic yield of temporal artery magnetic resonance angiography in the evaluation of giant cell arteritis. Rheumatology. 62:2197-2202. 2023
- Health Care Utilization in Systemic Sclerosis Patients With Digital Ulcers. Arthritis Care and Research. 75:1071-1078. 2023
- Neutrophil extracellular trap formation in anti-neutrophil cytoplasmic antibody-associated and large-vessel vasculitis. Clinical Immunology. 249:109274-109274. 2023
-
Damage Trajectories in Systemic Sclerosis Using
Group‐Based Trajectory Modeling. Arthritis Care and Research. 75:640-647. 2023 - Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. The Lancet Respiratory Medicine. 11:87-96. 2023
- Vitamin D status in ANCA-associated vasculitis. Rheumatology Advances in Practice. 7:rkad021. 2022
- Randomized controlled trial of an internet-based self-guided hand exercise program to improve hand function in people with systemic sclerosis: the Scleroderma Patient-centered Intervention Network Hand Exercise Program (SPIN-HAND) trial. Trials. 23:994. 2022
- 2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis. Arthritis & Rheumatology. 74:1881-1889. 2022
- 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.. Arthritis & Rheumatology. 81:1654-1660. 2022
- Airway autoantibodies are determinants of asthma severity. European Respiratory Journal. 60:2200442-2200442. 2022
- Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis. Respiratory Research. 23:54. 2022
- Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis. Arthritis Research & Therapy. 24:160. 2022
- Geographical distribution of systemic sclerosis in Canada: An ecologic study based on the Canadian Scleroderma Research Group. Journal of American Academy of Dermatology. 87:1095-1097. 2022
- Severe ophthalmic involvement in granulomatosis with polyangiitis resistant to cyclophosphamide. Canadian Journal of Ophthalmology. 57:e162-e162. 2022
- Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT. Health Technology Assessment. 26:1-60. 2022
- Hypothyroidism in vasculitis. Rheumatology. 61:2942-2950. 2022
- Self-Reported Data and Physician-Reported Data in Patients With Eosinophilic Granulomatosis With Polyangiitis: Comparative Analysis. Interactive Journal of Medical Research. 11:e27273-e27273. 2022
- Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry. Journal of Rheumatology. 49:447-453. 2022
- Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity. European Respiratory Journal. 59:2102210-2102210. 2022
- Variations in Takayasu arteritis characteristics in a cohort of patients with different racial backgrounds. Seminars in Arthritis and Rheumatism. 53:151971-151971. 2022
- 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis. Arthritis & Rheumatology. 74:386-392. 2022
- 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis.. Arthritis & Rheumatology. 81:315-320. 2022
- 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis.. Arthritis & Rheumatology. 81:321-326. 2022
- Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program. Pilot and Feasibility Studies. 8:45. 2022
- A196 DIARRHEA AS A PRESENTING SYMPTOM OF RELAPSED GRANULOMATOSIS WITH POLYANGIITIS. Journal of the Canadian Association of Gastroenterology. 5:81-82. 2022
- Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort. PLoS ONE. 17:e0274264-e0274264. 2022
- Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts. Journal of Rheumatology. 49:16-25. 2022
- Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis. Chest. 160:2158-2162. 2021
- Pain levels and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a multicentre cross-sectional study. The Lancet Rheumatology. 3:e844-e854. 2021
- The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial. Trials. 22:856. 2021
- Value of second opinion subspecialty radiology consultation in suspected abdominal medium vessel vasculitis. Abdominal Radiology. 46:5763-5771. 2021
- Fecal microbiome differs between patients with systemic sclerosis with and without small intestinal bacterial overgrowth. Journal of Scleroderma and Related Disorders. 6:290-298. 2021
- Contextualizing temporal arterial magnetic resonance angiography in the diagnosis of giant cell arteritis: a retrospective cohort study. Rheumatology. 60:4229-4237. 2021
- Clinical Manifestations and Long‐Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North America. ACR Open Rheumatology. 3:404-412. 2021
- Esophageal Obstruction Secondary to Massive Tumoral Calcinosis. Journal of Rheumatology. 48:786-786. 2021
- CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update. Journal of Rheumatology. 48:555-566. 2021
- Sequence‐Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2. Arthritis & Rheumatology. 73:512-519. 2021
- Association between age at disease onset of anti-neutrophil cytoplasmic antibody–associated vasculitis and clinical presentation and short-term outcomes. Rheumatology. 60:617-628. 2021
- Efficacy of leflunomide in the treatment of vasculitis. Clinical and Experimental Rheumatology. 39:S114-S118. 2021
- Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study. Journal of Psychosomatic Research. 140:110314-110314. 2021
- Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study. American Journal of Human Genetics. 108:84-99. 2021
- Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study. Journal of Psychosomatic Research. 139:110262-110262. 2020
- Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS). Arthritis Research & Therapy. 22:132. 2020
- Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell Arteritis. Arthritis Care and Research. 72:1615-1624. 2020
- Involvement of the intracranial circulation in giant cell arteritis. Canadian Journal of Ophthalmology. 55:391-400. 2020
- Updates in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis: At a crossroad. Presse Medicale. 49:104038-104038. 2020
- Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis. Annals of the Rheumatic Diseases. 79:1243-1249. 2020
- Characteristics of Takayasu Arteritis Patients with Severe Ischemic Events. Journal of Rheumatology. 47:1224-1228. 2020
- Patterns of clinical presentation in Takayasu's arteritis. Seminars in Arthritis and Rheumatism. 50:576-581. 2020
- Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients. Journal of Psychosomatic Research. 135:110132-110132. 2020
- Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis. Journal of Rheumatology. 47:1001-1010. 2020
- Mammalian target of rapamycin is activated in the kidneys of patients with scleroderma renal crisis. Journal of Scleroderma and Related Disorders. 5:152-158. 2020
- THU0318 PATTERNS OF CLINICAL PRESENTATION IN TAKAYASU’S ARTERITIS. Annals of the Rheumatic Diseases. 79:388.1-388. 2020
- Derivation of an angiographically based classification system in Takayasu’s arteritis: an observational study from India and North America. Rheumatology. 59:1118-1127. 2020
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. New England Journal of Medicine. 382:622-631. 2020
- Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity. Rheumatology. 59:398-406. 2020
- Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology Dialysis Transplantation. 35:283-291. 2020
- Methods for shortening patient-reported outcome measures. Statistical Methods in Medical Research. 28:2992-3011. 2019
- Collection of antirheumatic medication data from both patients and rheumatologists shows strong agreement in a real-world clinical cohort: the Ontario Best Practices Research Initiative—a rheumatoid arthritis cohort. Journal of Clinical Epidemiology. 114:95-103. 2019
- Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results. Journal of Rheumatology. 46:874-886. 2019
- Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic Vasculitis. Journal of Rheumatology. 46:928-934. 2019
- Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis. Annals of the Rheumatic Diseases. 78:807-816. 2019
- Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality. Rheumatology. 58:636-644. 2019
- 020. IDENTIFICATION OF TARGET ANTIGENS FOR ANTI-ENDOTHELIAL CELL ANTIBODIES IN PATIENTS WITH TAKAYASU’S ARTERITIS USING PROTEOMICS. Rheumatology. 58:kez057.019. 2019
- 035. CANDIDATE BIOMARKERS IN ANCA-ASSOCIATED VASCULITIS IDENTIFIED USING A PROTEOMIC APPROACH. Rheumatology. 58:kez057.034. 2019
- 043. SUBGLOTTIC STENOSIS AND ENDOBRONCHIAL DISEASE IN GRANULOMATOSIS WITH POLYANGIITIS. Rheumatology. 58:kez057.042. 2019
- 045. EVALUATION OF NOVEL SERUM BIOMARKERS OF DISEASE ACTIVITY IN GIANT CELL ARTERITIS, TAKAYASU’S ARTERITIS, POLYARTERITIS NODOSA, AND EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS. Rheumatology. 58:kez057.044. 2019
- 083. COMPARISON OF ARTERIAL PATTERNS OF DISEASE IN TAKAYASU’S ARTERITIS AND GIANT CELL ARTERITIS. Rheumatology. 58:kez058.023. 2019
- 084. DISCOVERY AND VALIDATION OF A NOVEL ANGIOGRAPHIC CLASSIFICATION SCHEME IN TAKAYASU’S ARTERITIS. Rheumatology. 58:kez058.024. 2019
- 090. A CLINICAL SCORING SYSTEM FOR RISK STRATIFICATION OF GIANT CELL ARTERITIS. Rheumatology. 58:kez058.030. 2019
- 138. DIFFUSE ALVEOLAR HEMORRHAGE, PULMONARY NODULES AND INFILTRATES IN GRANULOMATOSIS POLYANGIITIS AND MICROSCOPIC POLYANGIITIS. A COHORT STUDY OF 736 PATIENTS. Rheumatology. 58:kez059.015. 2019
- 139. UTILIZATION OF CANADIAN HEALTHCARE ADMINISTRATIVE DATABASES TO ACCURATELY IDENTIFY CASES OF ANCA-ASSOCIATED VASCULITIS. Rheumatology. 58:kez059.016. 2019
- 148. SHORT-FORM 36 AS A MEASURE OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH GIANT CELL ARTERITIS. Rheumatology. 58:kez059.025. 2019
- 275. FACTORS ASSOCIATED WITH DISEASE PROGRESSION IN PATIENTS WITH MYELOPEROXIDASE-ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-RELATED PULMONARY FIBROSIS. Rheumatology. 58:kez062.049. 2019
- Arterial lesions in giant cell arteritis: A longitudinal study. Seminars in Arthritis and Rheumatism. 48:707-713. 2019
- Presentation and Disease Course of Childhood‐Onset Versus Adult‐Onset Takayasu Arteritis. Arthritis & Rheumatology. 71:315-323. 2019
- Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort. BMJ Open. 9:e024010-e024010. 2019
- Sputum Antineutrophil Cytoplasmic Antibodies in Serum Antineutrophil Cytoplasmic Antibody–Negative Eosinophilic Granulomatosis with Polyangiitis. American Journal of Respiratory and Critical Care Medicine. 199:158-170. 2019
- <p>Neural network and logistic regression diagnostic prediction models for giant cell arteritis: development and validation</p>. Clinical Ophthalmology. Volume 13:421-430. 2019
- Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma. Clinical and Experimental Rheumatology. 37:S40-S44. 2019
- Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma.. Clinical and Experimental Rheumatology. 37 Suppl 117:40-44. 2019
- ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI). RMD Open. 4:e000738-e000738. 2018
- Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study. Arthritis Care and Research. 70:1646-1652. 2018
- Interstitial lung disease is associated with an increased risk of lung cancer in systemic sclerosis: Longitudinal data from the Canadian Scleroderma Research Group. Journal of Scleroderma and Related Disorders. 3:221-227. 2018
- Serum S100 Proteins as a Marker of Disease Activity in Large Vessel Vasculitis. Journal of Clinical Rheumatology. 24:393-395. 2018
- Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study. Arthritis Care and Research. 70:1557-1562. 2018
- The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts. Rheumatology. 57:1623-1631. 2018
- LB01THE EFFECT OF PLASMA EXCHANGE ON END STAGE RENAL DISEASE AND DEATH IN PATIENTS WITH SEVERE ANCA ASSOCIATED VASCULITIS. Nephrology Dialysis Transplantation. 33:i636-i636. 2018
- LB02THE EFFECT OF REDUCED-DOSE GLUCOCORTICOIDS DURING REMISSION INDUCTION IN SEVERE ANCA ASSOCIATED VASCULITIS. Nephrology Dialysis Transplantation. 33:i636-i636. 2018
- Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype. Autoimmunity Reviews. 17:267-275. 2018
- Evaluation of damage in giant cell arteritis. Rheumatology. 57:322-328. 2018
- Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network hand exercise program (SPIN-HAND): Study protocol. Journal of Scleroderma and Related Disorders. 3:91-97. 2018
- Validation of the Social Interaction Anxiety Scale in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort study. Journal of Scleroderma and Related Disorders. 3:98-105. 2018
- Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy. Allergy, Asthma and Clinical Immunology. 13:2. 2017
- Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise. Journal of Rheumatology. 44:1928-1932. 2017
- What have multicentre registries across the world taught us about the disease features of systemic sclerosis?. Journal of Scleroderma and Related Disorders. 2:169-182. 2017
- Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort. Rheumatology. 56:1111-1122. 2017
- Early Mortality in a Multinational Systemic Sclerosis Inception Cohort. Arthritis & Rheumatology. 69:1067-1077. 2017
- Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis. Arthritis & Rheumatology. 69:1054-1066. 2017
- Correction: Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy. Scientific Reports. 7:46012. 2017
- A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis. Arthritis & Rheumatology. 69:837-845. 2017
- A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Takayasu Arteritis. Arthritis & Rheumatology. 69:846-853. 2017
- Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues. Rheumatology. 56:kew441-kew441. 2017
- Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy. Scientific Reports. 7:43953. 2017
- IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Clinical and Experimental Rheumatology. 35:S98-S101. 2017
- Validation of the Body Concealment Scale for Scleroderma (BCSS): Replication in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort. Body Image. 20:99-106. 2017
- WS1_1 Sputum Anti-neutrophil Cytoplasmic Antibodies (ANCA) in Eosinophilic Granulamatosis and Polyangiitis (eGPA). Rheumatology. 56:iii17-iii19. 2017
- Experience With Direct-to-Patient Recruitment for Enrollment Into a Clinical Trial in a Rare Disease: A Web-Based Study. Journal of Medical Internet Research. 19:e50-e50. 2017
- Reply. Arthritis & Rheumatology. 69:477-478. 2017
- The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients. Clinical Rheumatology. 36:373-379. 2017
- A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis. American Journal of Human Genetics. 100:64-74. 2017
- ANCA-associated pauci-immune glomerulonephritis in a patient with bacterial endocarditis: a challenging clinical dilemma. Clinical Nephrology - Case Studies. 5:32-37. 2017
- High‐Resolution Magnetic Resonance Imaging of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Cohort Study. Arthritis & Rheumatology. 69:161-168. 2017
- IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss).. Clinical and Experimental Rheumatology. 35 Suppl 103:98-101. 2017
- Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis.. Clinical and Experimental Rheumatology. 35 Suppl 106:56-60. 2017
- The Comparability of Functional Assessment of Chronic Illness Therapy - Fatigue Scores between Cancer and Systemic Sclerosis. Journal of Scleroderma and Related Disorders. 2:57-63. 2017
- Calcinosis is associated with digital ischaemia in systemic sclerosis—a longitudinal study. Rheumatology. 55:2148-2155. 2016
- Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients. Arthritis Research & Therapy. 18:20. 2016
- Using Optimal Test Assembly Methods for Shortening Patient‐Reported Outcome Measures: Development and Validation of the Cochin Hand Function Scale‐6: A Scleroderma Patient‐Centered Intervention Network Cohort Study. Arthritis Care and Research. 68:1704-1713. 2016
- An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial. Journal of Rheumatology. 43:1672-1679. 2016
- P086 <break /> Prevalence of finger clubbing in Interstitial Lung Diseases. QJM - Monthly Journal of the Association of Physicians. 109:s51-s51. 2016
- Subsets in systemic sclerosis: one size does not fit all. Journal of Scleroderma and Related Disorders. 1:298-306. 2016
- Development and Validation of the Body Concealment Scale for Scleroderma. Arthritis Care and Research. 68:1158-1165. 2016
- Using Marital Status and Continuous Marital Satisfaction Ratings to Predict Depressive Symptoms in Married and Unmarried Women With Systemic Sclerosis: A Canadian Scleroderma Research Group Study. Arthritis Care and Research. 68:1143-1149. 2016
- Validation of the Self‐Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient‐Centered Intervention Network Cohort Study. Arthritis Care and Research. 68:1195-1200. 2016
- The Impact of Pain and Itch on Functioning and Health-Related Quality of Life in Systemic Sclerosis: An Exploratory Study. Journal of Pain and Symptom Management. 52:43-53. 2016
- The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis. Journal of Rheumatology. 43:1078-1084. 2016
- How to Attract Trainees, a Pan-Canadian Perspective: Phase 1 of the “Training the Rheumatologists of Tomorrow” Project. Journal of Rheumatology. 43:788-798. 2016
- Severe Intracranial Involvement in Giant Cell Arteritis: 5 Cases and Literature Review. Journal of Rheumatology. 43:648-656. 2016
- Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature. Seminars in Arthritis and Rheumatism. 45:475-482. 2016
- CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides. Journal of Rheumatology. 43:97-120. 2016
- Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.. Clinical and Experimental Rheumatology. 34 Suppl 100:92-99. 2016
- Polyarteritis nodosa – Challenges and options in management. Indian Journal of Rheumatology. 10:S64-S71. 2015
- Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects. Autoimmunity. 48:542-551. 2015
- Thinking outside the box—The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect. Seminars in Arthritis and Rheumatism. 45:184-189. 2015
- Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis. Rheumatology. 54:1351-1359. 2015
- Cardiac Involvement in Granulomatosis with Polyangiitis. Journal of Rheumatology. 42:1209-1212. 2015
- Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study. Journal of Rheumatology. 42:1213-1217. 2015
- Antinuclear antibody-negative systemic sclerosis. Seminars in Arthritis and Rheumatism. 44:680-686. 2015
- Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome‐Wide Association Study. Arthritis & Rheumatology. 67:1361-1368. 2015
- Development of Canadian Recommendations for the Management of ANCA-Associated Vasculitides: Results of the National Needs Assessment Questionnaire. Open Rheumatology Journal. 9:16-20. 2015
- 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Outperform the 1980 Criteria: Data From the Canadian Scleroderma Research Group. Arthritis Care and Research. 67:582-587. 2015
- A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility. American Journal of Human Genetics. 96:565-580. 2015
- Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts. Clinical and Experimental Rheumatology. 33:S77-S83. 2015
- CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody (ANCA)-Associated Vasculitides – Executive Summary. Canadian Journal of Kidney Health and Disease. 2:78-78. 2015
- Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts.. Clinical and Experimental Rheumatology. 33:S-77-83. 2015
- Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.. Clinical and Experimental Rheumatology. 33:S131-S135. 2015
- Serum Biomarkers in Patients with Relapsing Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss). PLoS ONE. 10:e0121737-e0121737. 2015
- Systemic Sclerosis Sine Scleroderma: A Multicenter Study of 1417 Subjects. Journal of Rheumatology. 41:2179-2185. 2014
- Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis—Results from the International Scleroderma Renal Crisis Survey. Seminars in Arthritis and Rheumatism. 43:666-672. 2014
- Effect of menopause on the modified Rodnan skin score in systemic sclerosis. Arthritis Research & Therapy. 16:R130-R130. 2014
- Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis. American Journal of Human Genetics. 94:47-61. 2014
- Systemic Sclerosis Immunoglobulin Induces Growth and a Pro-Fibrotic State in Vascular Smooth Muscle Cells through the Epidermal Growth Factor Receptor. PLoS ONE. 9:e100035-e100035. 2014
- New Features of Disease After Diagnosis in 6 Forms of Systemic Vasculitis. Journal of Rheumatology. 40:1905-1912. 2013
- MR Imaging of the Spine and Sacroiliac Joints for Spondyloarthritis: Influence on Clinical Diagnostic Confidence and Patient Management. Radiology. 269:208-215. 2013
- Association of Granulomatosis With Polyangiitis (Wegener's) With HLA–DPB1*04 and SEMA6A Gene Variants: Evidence From Genome‐Wide Analysis. Arthritis and Rheumatism. 65:2457-2468. 2013
- The 15% Rule in Scleroderma: The Frequency of Severe Organ Complications in Systemic Sclerosis. A Systematic Review. Journal of Rheumatology. 40:1545-1556. 2013
- Hypertensive Retinopathy in Takayasu Arteritis. Neuro-Ophthalmology. 37:157-158. 2013
- Identification of Multiple Genetic Susceptibility Loci in Takayasu Arteritis. American Journal of Human Genetics. 93:298-305. 2013
- Association of Gastroesophageal Factors and Worsening of Forced Vital Capacity in Systemic Sclerosis. Journal of Rheumatology. 40:850-858. 2013
- Radiology–pathology conference: neutrophilic fasciitis and panniculitis of the feet (Sweet's syndrome). Clinical Imaging. 37:608-612. 2013
- Urinary Biomarkers in Relapsing Antineutrophil Cytoplasmic Antibody-associated Vasculitis. Journal of Rheumatology. 40:674-683. 2013
- Does cigarette smoking mitigate the severity of skin disease in systemic sclerosis?. Rheumatology International. 33:943-948. 2013
- Longitudinal Study of Renal Function in Systemic Sclerosis. Journal of Rheumatology. 39:1829-1834. 2012
- Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis. Annals of the Rheumatic Diseases. 71:1329-1334. 2012
- Amyloidosis and Giant Cell Arteritis/Polymyalgia Rheumatica. Journal of Rheumatology. 39:878-880. 2012
- Clinical Correlates of CENP-A and CENP-B Antibodies in a Large Cohort of Patients with Systemic Sclerosis. Journal of Rheumatology. 39:787-794. 2012
- Agreement with Guidelines from a Large Database for Management of Systemic Sclerosis: Results from the Canadian Scleroderma Research Group. Journal of Rheumatology. 39:524-531. 2012
- Assessment of health‐related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's). Arthritis Care and Research. 64:273-279. 2012
- Association of Vascular Physical Examination Findings and Arteriographic Lesions in Large Vessel Vasculitis. Journal of Rheumatology. 39:303-309. 2012
- Circulating Angiopoietin-2 as a Biomarker in ANCA-Associated Vasculitis. PLoS ONE. 7:e30197-e30197. 2012
- IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. Proceedings of the National Academy of Sciences of the United States of America. 108:20736-20741. 2011
- Measuring Pain in Systemic Sclerosis: Comparison of the Short-form McGill Pain Questionnaire Versus a Single-item Measure of Pain. Journal of Rheumatology. 38:2581-2587. 2011
- Anti-Fibrillarin Antibody in African American Patients with Systemic Sclerosis: Immunogenetics, Clinical Features, and Survival Analysis. Journal of Rheumatology. 38:1622-1630. 2011
- Antiphospholipid Syndrome and the Aorta: A Rare Presentation. Journal of Rheumatology. 38:1808-1809. 2011
- ANCA-associated Vasculitides and Classification: A Conundrum Solved?. Journal of Rheumatology. 38:971-972. 2011
- Disability in Systemic Sclerosis — A Longitudinal Observational Study. Journal of Rheumatology. 38:685-692. 2011
- Observational Data to Study Medication Outcomes in Systemic Sclerosis: Table 1.. Journal of Rheumatology. 38:575.2-577. 2011
- The Effects of Needleless Connectors on Catheter-Related Thrombotic Occlusions. Journal of Infusion Nursing. 34:89-96. 2011
- Discordance between Patient and Physician Assessments of Disease Severity in Systemic Sclerosis. Journal of Rheumatology. 37:2307-2312. 2010
- The Association Between Disease Activity and Duration in Systemic Sclerosis. Journal of Rheumatology. 37:2299-2306. 2010
- Association of pruritus with quality of life and disability in systemic sclerosis. Arthritis Care and Research. 62:1489-1495. 2010
- Correction: Oral Contraceptives and Systemic Lupus Erythematosus, Current Practice in Hamilton. Journal of Rheumatology. 37:1788.2-1788. 2010
- Role of ultrasound in the management of rheumatological conditions of the hands and feet. International Journal of Clinical Rheumatology. 5:147-149. 2010
- Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care and Research. 62:409-417. 2010
- The Minimally Important Difference in Clinical Practice for Patient-centered Outcomes Including Health Assessment Questionnaire, Fatigue, Pain, Sleep, Global Visual Analog Scale, and SF-36 in Scleroderma. Journal of Rheumatology. 37:591-598. 2010
- Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. Arthritis and Rheumatism. 61:1765-1770. 2009
- Closing the osteoporosis care gap – Increased osteoporosis awareness among geriatrics and rehabilitation teams. BMC Geriatrics. 9:28. 2009
- Malnutrition Is Common in Systemic Sclerosis: Results from the Canadian Scleroderma Research Group Database. Journal of Rheumatology. 36:2737-2743. 2009
- Catastrophic Antiphospholipid Syndrome and Polyarteritis Nodosa. Journal of Rheumatology. 36:2619-2621. 2009
- Ultrasound of the hands and feet for rheumatological disorders: influence on clinical diagnostic confidence and patient management. Skeletal Radiology. 38:1049-1054. 2009
- Work Disability in Systemic Sclerosis. Journal of Rheumatology. 36:2481-2486. 2009
- Health‐related quality of life in systemic sclerosis: A systematic review. Arthritis and Rheumatism. 61:1112-1120. 2009
- Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: Evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis and Rheumatism. 61:966-973. 2009
- Bilateral tight swollen legs. Skeletal Radiology. 38:709-710. 2009
- Bilateral tight swollen legs: diagnosis and discussion. Skeletal Radiology. 38:729-730. 2009
- Validity of Self-Reported Comorbidities in Systemic Sclerosis: Table 1.. Journal of Rheumatology. 36:1477-1480. 2009
- Resident Evaluations: The Use of Daily Evaluation Forms in Rheumatology Ambulatory Care. Journal of Rheumatology. 36:1298-1303. 2009
- Role of Ultrasound in the Assessment of Small-Joint Synovitis. Canadian Association of Radiologists Journal. 60:69-70. 2009
- Reports of abnormal cervical cancer screening tests in systemic sclerosis. Rheumatology. 48:149-151. 2009
- The cost of systemic sclerosis. Arthritis and Rheumatism. 61:119-123. 2009
- Demographic and Clinical Factors Associated with Physician Service Use in Systemic Sclerosis. Journal of Rheumatology. 36:96-98. 2009
- Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review. Journal of Laryngology and Otology. 122:1371-1376. 2008
- Assessment of reproductive history in systemic sclerosis. Arthritis and Rheumatism. 59:1661-1664. 2008
- Chikungunya viral polyarthritis.. Journal of Rheumatology. 35:935-936. 2008
- Churg-Strauss syndrome and revascularization of the hand: a case report.. Journal of Rheumatology. 35:941-943. 2008
- Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis and Rheumatism. 59:504-509. 2008
- High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms. Arthritis and Rheumatism. 59:431-437. 2008
- Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis. Arthritis and Rheumatism. 59:438-443. 2008
- Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II. Arthritis and Rheumatism. 59:279-284. 2008
- Quality of life in systemic sclerosis: Psychometric properties of the World Health Organization Disability Assessment Schedule II. Arthritis and Rheumatism. 59:270-278. 2008
- Hypocomplementemia in systemic sclerosis--clinical and serological correlations.. Journal of Rheumatology. 34:2218-2223. 2007
- Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis.. Clinical and Experimental Rheumatology. 25:754-757. 2007
- Community-based evaluation of etanercept in patients with rheumatoid arthritis.. Journal of Rheumatology. 33:665-670. 2006
- International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis. Journal of the American Medical Association (JAMA). 295:180-180. 2006
- Coexisting Systemic Lupus Erythematosus and Sickle Cell Disease. Journal of Clinical Rheumatology. 11:86-92. 2005
- Metabolic complications of parenteral nutrition in adults, part 2. American Journal of Health-System Pharmacy. 61:2616-2616. 2004
- Recalcitrant steroid-resistant EGPA with multisystem involvement. Case Reports in Internal Medicine. 4:12-12.
-
preprints
- Autoinflammatory Gene Mutations Associated with Eosinophilia and Asthma 2023
- Biologic DMARD Access and Medication Cost-related Nonadherence in Rheumatology Patients in Canada: A Cross-sectional Survey 2023
- Self-Reported Data and Physician-Reported Data in Patients With Eosinophilic Granulomatosis With Polyangiitis: Comparative Analysis (Preprint) 2021